The Role of Text Mining at
Boehringer Ingelheim Pharmaceuticals
Tuesday, February 23, 2016
9:00 AM (3:00 PM CET) and 1:00 PM EST (7:00 PM CET)
Text mining is beginning to establish its place across the life sciences industry as a way for researchers to quickly analyze massive amounts of literature, as well as conference abstracts, patents and clinical data to help inform and guide R&D. From drug discovery and clinical trial development to drug safety monitoring and competitive intelligence, text mining has many applications for life science companies.
Join Jon Hill, Principal Scientist in Computational Biology at Boehringer Ingelheim Pharmaceuticals, as he discusses the application, outcomes and business value of text mining, its impact on early drug discovery, and what the future may hold.
In this session, Jon will also explore:
- The various sources of text-based data
- The impact of mixing data types
- How text mining works in practice
- Mining full-text articles versus abstracts
Copyright Clearance Center (CCC), a leading global rights-licensing technology organization, provides solutions that simplify compliance for content users, promotes the work of creators and supports the principles of copyright. A rights broker for the world’s most sought-after journals, books, blogs, movies and more, CCC makes it easy for businesses and academic institutions to use, share and store copyrighted material while compensating content creators for their works. With its international subsidiary,RightsDirect, CCC serves more than 35,000 customers and 12,000 publishers around the world.
Jon Hill is a Principal Scientist for the Computational Biology group at Boehringer Ingelheim, with a focus on new target concept discovery from public and proprietary data. He obtained a M.S. in Applied Genomics from the University of Connecticut and a Masters in Library and Information Science from Southern Connecticut State University, and has over 12 years of experience in the pharmaceutical industry. His current research focuses on understanding disease mechanisms in inflammatory and renal diseases through next generation sequencing analysis and analysis of databases and unstructured text.
We respect your right to privacy - view our policy
Featured Speaker: Jon Hill